New emerging roles of microRNAs in breast cancer

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2018-06-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-018-4850-7PMID 29948402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.

  2017cited by this paper
• Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells

  2017cited by this paper
• Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells

  2017cited by this paper
• miRNA-Mediated RNA Activation in Mammalian Cells.

  2017cited by this paper
• Impaired expression of Drosha in breast cancer.

  2017cited by this paper
• Restoration of miR-143 expression could inhibit migration and growth of MDA-MB-468 cells through down-regulating the expression of invasion-related factors.

  2017cited by this paper
• MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer

  2017cited by this paper
• MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer

  2017cited by this paper
• Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer

  2017cited by this paper
• Oncogenic long noncoding RNA landscape in breast cancer

  2017cited by this paper
• Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.

  2017cited by this paper
• Cap-binding protein 4EHP effects translation silencing by microRNAs

  2017cited by this paper
• miRNA expression profile in multicellular breast cancer spheroids.

  2017cited by this paper
• miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers

  2017cited by this paper
• Differential response of normal and transformed mammary epithelial cells to combined treatment of anti-miR-21 and radiation

  2017cited by this paper
• MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

  2017cited by this paper
• Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells.

  2017cited by this paper
• Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer.

  2017cited by this paper
• Exploring Mechanisms of MicroRNA Downregulation in Cancer.

  2017cited by this paper
• A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer

  2017cited by this paper
• Role of microRNAs in translation regulation and cancer

  2017cited by this paper
• Treating Cancer by Targeting Telomeres and Telomerase

  2017cited by this paper
• Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.

  2017cited by this paper
• Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway.

  2016cited by this paper
• MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.

  2016cited by this paper
• Plasma exosome microRNAs are indicative of breast cancer

  2016cited by this paper
• Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

  2016cited by this paper
• miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation

  2016cited by this paper
• Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.

  2016cited by this paper
• Endogenous microRNA sponges: evidence and controversy

  2016cited by this paper
• miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.

  2016cited by this paper
• Profiling of microRNAs in tumor interstitial fluid of breast tumors – a novel resource to identify biomarkers for prognostic classification and detection of cancer

  2016cited by this paper
• microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7

  2016cited by this paper
• 3B, a novel photosensitizer, inhibits glycolysis and inflammation via miR-155-5p and breaks the JAK/STAT3/SOCS1 feedback loop in human breast cancer cells.

  2016cited by this paper
• MicroRNA profiling in human breast cancer cell lines exposed to the anti-neoplastic drug cediranib.

  2016cited by this paper
• miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.

  2016cited by this paper
• MiR‐107 down‐regulates SIAH1 expression in human breast cancer cells and silencing of miR‐107 inhibits tumor growth in a nude mouse model of triple‐negative breast cancer

  2016cited by this paper
• Upregulation of the double-stranded RNA binding protein DGCR8 in invasive ductal breast carcinoma.

  2016cited by this paper
• MiR-18a upregulation decreases Dicer expression and confers paclitaxel resistance in triple negative breast cancer.

  2016cited by this paper
• MicroRNA‐107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain‐derived neurotrophic factor

  2016cited by this paper
• Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression

  2016cited by this paper
• Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer

  2016cited by this paper
• MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha

  2016cited by this paper
• Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes

  2016cited by this paper
• miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation

  2016cited by this paper
• miR-155 Overexpression Promotes Genomic Instability by Reducing High-fidelity Polymerase Delta Expression and Activating Error-Prone DSB Repair

  2016cited by this paper
• The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer

  2016cited by this paper
• Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

  2015cited by this paper
• Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis

  2015cited by this paper
• Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential

  2015cited by this paper
• Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells

  2015cited by this paper
• Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

  2015cited by this paper
• Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221

  2015cited by this paper
• RNA Polymerase III Regulates Cytosolic RNA:DNA Hybrids and Intracellular MicroRNA Expression*

  2015cited by this paper
• MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.

  2015cited by this paper
• MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour

  2015cited by this paper
• Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR

  2015cited by this paper
• MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.

  2014cited by this paper
• miR-221/222 control luminal breast cancer tumor progression by regulating different targets

  2014cited by this paper
• LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis

  2014cited by this paper
• MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin

  2014cited by this paper
• miR-155 drives telomere fragility in human breast cancer by targeting TRF1.

  2014cited by this paper
• The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs

  2014cited by this paper
• microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

  2014cited by this paper
• MicroRNA‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2

  2014cited by this paper
• Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.

  2014cited by this paper
• Complexity in Regulation of microRNA Machinery Components in Invasive Breast Carcinoma

  2014cited by this paper
• miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer

  2014cited by this paper
• miR-27a regulates endothelial differentiation of breast cancer stem like cells

  2014cited by this paper
• Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA

  2014cited by this paper
• MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN

  2014cited by this paper
• microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer

  2014cited by this paper
• hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3

  2014cited by this paper
• Multiple Tumor Suppressor microRNAs Regulate Telomerase and TCF7, an Important Transcriptional Regulator of the Wnt Pathway

  2014cited by this paper
• STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes

  2014cited by this paper
• MicroRNAs, Genomic Instability and Cancer

  2014cited by this paper
• miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

  2014cited by this paper
• MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability

  2014cited by this paper
• miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer

  2014cited by this paper
• MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

  2013cited by this paper
• Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

  2013cited by this paper
• Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status

  2013cited by this paper
• Tumour angiogenesis regulation by the miR-200 family

  2013cited by this paper
• MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1

  2013cited by this paper
• MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer

  2013cited by this paper
• In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging

  2013cited by this paper
• miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer

  2013cited by this paper
• miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w.

  2012cited by this paper
• A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells

  2012cited by this paper
• Battle of the midgets

  2012cited by this paper
• MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells.

  2012cited by this paper
• miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer

  2011cited by this paper
• Widespread regulatory activity of vertebrate microRNA* species.

  2011cited by this paper
• MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer.

  2011cited by this paper
• Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.

  2011cited by this paper
• MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU

  2010cited by this paper
• Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.

  2010cited by this paper
• miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway.

  2010cited by this paper

• microRNAs as Biomarkers of Breast Cancer

  2025cites this paper
• Non-Coding RNAs Extended Omnigenic Module of Cancers

  2024influential citation
• An in vitro assessment of ionizing radiation impact on the efficacy of radiotherapy for breast cancer

  2024cites this paper
• Epigenetics in Canine Mammary Tumors: Upregulation of miR-18a and miR-18b Oncogenes Is Associated with Decreased ERS1 Target mRNA Expression and ERα Immunoexpression in Highly Proliferating Carcinomas

  2023cites this paper
• Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy

  2023cites this paper
• Potential roles of the exosome/microRNA axis in breast cancer.

  2023cites this paper
• Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer

  2023cites this paper
• Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review

  2023cites this paper
• The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy

  2023cites this paper
• MiR-556-5p modulates migration, invasion, and epithelial-mesenchymal transition in breast cancer cells via targeting PTHrP

  2022cites this paper
• Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion

  2022cites this paper
• MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer

  2022cites this paper
• The role of epigenetic modifications in drug resistance and treatment of breast cancer

  2022cites this paper
• Circulating miRNAs in Breast Cancer Diagnosis and Prognosis

  2022cites this paper
• Current and Developing Liquid Biopsy Techniques for Breast Cancer

  2022cites this paper
• miR-31, miR-155, and miR-221 expression profiles and their association with graft skin tolerance in a syngeneic vs. allogeneic murine skin transplantation model.

  2022cites this paper
• Regulatory MicroRNAs in T2DM and Breast Cancer

  2021cites this paper
• Diagnosis, biology and epidemiology of oligometastatic breast cancer

  2021cites this paper
• A hybrid CNN-LSTM model for pre-miRNA classification

  2021cites this paper
• Uncovering the roles of microRNAs/lncRNAs in characterising breast cancer subtypes and prognosis

  2021cites this paper
• An overview on breast cancer genetics and recent innovations: Literature survey

  2021cites this paper
• Hsa‐miR‐599 inhibits breast cancer progression via BRD4/Jagged1/Notch1 axis

  2021cites this paper
• miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2

  2021cites this paper
• MicroRNAs as a clue to overcome breast cancer treatment resistance

  2021cites this paper
• Supervised Deep Learning Methods for Human pre-miRNA Identification

  2020cites this paper
• Deep neural networks for human microRNA precursor detection

  2020cites this paper
• Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor

  2020cites this paper
• Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.

  2020cites this paper
• Long noncoding RNA RUSC1-AS1 promotes tumorigenesis in cervical cancer by acting as a competing endogenous RNA of microRNA-744 and consequently increasing Bcl-2 expression

  2020cites this paper
• Association between Lymph Node Status and Expression Levels of Androgen Receptor, miR-185, miR-205, and miR-21 in Breast Cancer Subtypes

  2020cites this paper
• Prediction of miRNA targets by learning from interaction sequences

  2020cites this paper
• Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.

  2020cites this paper
• Role of microRNA in forming breast carcinoma.

  2020cites this paper
• Polymorphism of lncRNAs in breast cancer: Meta‐analysis shows no association with susceptibility

  2020influential citation
• Epigenetic Therapies in the Precision Medicine Era

  2020cites this paper
• MiR-222-5p promotes the growth and migration of trophoblasts by targeting AHNAK.

  2020cites this paper
• GPER1 and microRNA: Two Players in Breast Cancer Progression

  2020cites this paper
• MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells

  2019influential citation
• Nucleotide-level Convolutional Neural Networks for Pre-miRNA Classification

  2019cites this paper
• A Mixed Convolutional Neural Network for Pre-miRNA Classification

  2019cites this paper
• Effects of miR-376 family miRNAs on CHRNA5 depleted MCF7 cell line model and co-culture competition studies

  2019cites this paper
• Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers

  2019cites this paper
• Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer

  2019cites this paper
• The Anticancer Properties of Silibinin: its Molecular Mechanism and Therapeutic Effect in Breast Cancer.

  2019cites this paper
• MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer

  2019cites this paper
• The Regulatory Role of MicroRNAs in Breast Cancer

  2019cites this paper
• The Role of miRNAs from the 14q32 Region in Acquired Resistance to Lapatinib

  2019cites this paper
• MicroRNA-876 is sponged by long noncoding RNA LINC00707 and directly targets metadherin to inhibit breast cancer malignancy

  2019cites this paper
• MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.

  2019cites this paper
• Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors

  2019cites this paper
• MicroRNAs in Bone Metastasis

  2019cites this paper
• Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors

  2019cites this paper
• MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.

  2019cites this paper
• Identification of genes associated with survival of breast cancer patients

  2018cites this paper
• The quantum language of the microRNA gene and anti-cancer: with a dynamic computer simulation of human breast cancer drug resistance

  2018cites this paper